Skip navigation
Skip navigation

Cost-effectiveness of 3 months of weekly rifapentine and isoniazid compared with other standard treatment regimens for latent tuberculosis infection: a decision analysis study

Doan, Tan N; Fox, Greg; Meehan, Michael; Nick, Scott; Ragonnet, Romain; Viney, Kerri; Trauer, James; McBryde, Emma

Description

Latent tuberculosis infection (LTBI) is a critical driver of the global burden of active TB, and therefore LTBI treatment is key for TB elimination. Treatment regimens for LTBI include self-administered daily isoniazid for 6 (6H) or 9 (9H) months, self-administered daily rifampicin plus isoniazid for 3 months (3RH), self-administered daily rifampicin for 4 months (4R) and weekly rifapentine plus isoniazid for 3 months self-administered (3HP-SAT) or administered by a healthcare worker as...[Show more]

CollectionsANU Research Publications
Date published: 2019
Type: Journal article
URI: http://hdl.handle.net/1885/172083
Source: Journal of Antimicrobial Chemotherapy
DOI: 10.1093/jac/dky403

Download

File Description SizeFormat Image
01_Doan_Cost-effectiveness_of_3%E2%80%89months_2019.pdf492.15 kBAdobe PDF    Request a copy


Items in Open Research are protected by copyright, with all rights reserved, unless otherwise indicated.

Updated:  19 May 2020/ Responsible Officer:  University Librarian/ Page Contact:  Library Systems & Web Coordinator